Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, covering all aspects of healthcare, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies, and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest

Mar 23, 2017, 05:46 ET Edison Issues Outlook on ReNeuron Group (RENE)

ReNeuron reported in December 2016 positive Phase II trial data for its CTX cells in chronic stroke patients, despite not meeting the three-month...


Mar 22, 2017, 17:16 ET New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients

Global biotherapeutics leader CSL Behring today announced that results were published in the New England Journal of Medicine (NEJM) from the...


Mar 22, 2017, 16:01 ET DarioHealth Reports Fourth Quarter and Year End 2016 Results

DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today reported financial and...


Mar 22, 2017, 12:55 ET Neurosurgical Practices Must Evolve and Transform to Adapt to Rapidly Changing Healthcare Industry

Neurosurgeons hoping to successfully navigate the rapidly changing healthcare industry must advance their strategies and adapt new ways of thinking...


Mar 22, 2017, 10:00 ET Morphotek And Sandy Rollman Ovarian Cancer Foundation Launch Educational Resource On Clinical Trials

Morphotek®, Inc., a subsidiary of Eisai Inc., and the Sandy Rollman Ovarian Cancer Foundation (SROCF) announced today the launch of a resource to...


Mar 22, 2017, 09:00 ET R-D Rapid Disinfector Outperforms Competitive UV-C Disinfection System in an Independent Study

A new independent study demonstrates that the Steriliz R-D™ Rapid Disinfector™ is the proven ultraviolet-C (UV-C) disinfection solution of choice...


Mar 22, 2017, 09:00 ET Newton-Wellesley Hospital's Early Detection Initiative Improves Clinical Outcomes, Reduces Nurse Alarm Response Time by 59%

EarlySense, the market leader in Contact-Free Continuous Monitoring solutions, announced today that Newton-Wellesley Hospital, a nationally...


Mar 22, 2017, 08:45 ET Oramed to Present at Oligonucleotide and Peptide Therapeutics (OPT) Boston Conference on March 28, 2017

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...


Mar 22, 2017, 08:01 ET Endotronix Strengthens Management Team with Seasoned Medtech Executives

Endotronix, Inc., a digital health medtech company providing innovative solutions for patients who suffer from advanced heart failure, today...


Mar 22, 2017, 08:01 ET Biosensors Announces Enrollment of the First American Patient in the New US Pivotal Biofreedom Trial - "LEADERS FREE II"

Biosensors International Group, Ltd. ("Biosensors" or the "Company"), a developer, manufacturer and marketer of innovative medical devices,...


Mar 22, 2017, 08:00 ET Bayer to Showcase Data on Growing Oncology Pipeline at AACR 2017

Bayer announced today that the latest research from its growing oncology portfolio will be presented at the American Association for Cancer...


Mar 22, 2017, 08:00 ET Aprea Therapeutics Announces Research Collaboration with Memorial Sloan Kettering Cancer Center

Aprea Therapeutics, a privately held, clinical stage biopharmaceutical company developing novel anticancer therapies targeting the tumor suppressor...


Mar 22, 2017, 08:00 ET ClarVista Medical Completes Important Milestone to Advance Novel Modular Intraocular Lens for Cataract Lens Replacement

ClarVista Medical, Inc. ("ClarVista"), a privately-held ophthalmic device company developing the HARMONI Modular IOL System, a novel intraocular...


Mar 22, 2017, 07:00 ET Compugen to Present CGEN-15001 Autoimmune Product Candidate at Upcoming Conferences

Compugen Ltd. (NASDAQ: CGEN), a therapeutic discovery company, announced today that abstracts highlighting CGEN-15001, the Company's autoimmune...


Mar 22, 2017, 07:00 ET Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies

Expects Phase I Results in the Third Quarter of 2017 Intec Pharma Ltd. (Nasdaq; TASE: NTEC), a clinical stage biopharmaceutical company focused...


Mar 22, 2017, 07:00 ET Shire Receives FDA Fast Track Designation for Recombinant ADAMTS13 (SHP655) for Treatment of Hereditary Thrombotic Thrombocytopenic Purpura

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation...


Mar 21, 2017, 14:01 ET OncoSec Medical's Intratumoral Plasmid IL-12 Demonstrates Effectiveness at Enhancing Tumor Immunogenicity in Preclinical Tumor Models

OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, today presented a...


Mar 21, 2017, 13:41 ET Caution needed for drugs in development for most common malignant pediatric brain tumor

Researchers led by St. Jude Children's Research Hospital scientists have worked out how a crucial cancer-related protein, a "histone writer" called...


Mar 21, 2017, 09:40 ET Pulmatrix Receives European Patent for its Inhaled Drug Delivery Technology

Pulmatrix, Inc. (NASDAQ: PULM), a clinical stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary...


Mar 21, 2017, 09:18 ET Entwicklung von PARI Pharma mit eFlow Technologie gegen Bronchiolitis Obliterans Syndrom (BOS) wird an Breath Therapeutics lizenziert

PARI Pharma, ein Unternehmen mit Schwerpunkt auf der Optimierung von Arzneimittel-Medizinprodukt-Kombinationen, hat sein...